Implementation of Substance Use Treatment in Ambulatory Care

This brief reviews opioid and stimulant trends in availability, use, and impacts; compares opioids and stimulants in terms of drug effects and motivations for use; and examines the factors that drive co-use.

This guide describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources for treating stimulant use disorders.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

This “how-to” guide provides physician practices and health systems with practical strategies, actionable steps and evidence-based resources for identifying and addressing unhealthy substance use or misuse in their patients.

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.

This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.

This page is designed for people who use drugs or have substance use disorder; their friends, family, and loved ones; and the general public.

May 2021, SAMHSA revised certain areas of all five parts of this TIP to bring the content up to date and make it as useful to readers as possible. These changes will help provide readers with the latest information needed to understand medications for opioid use disorder.

This Advisory is based on TIP 50, Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment. It provides strategies for identifying and addressing suicidal thoughts and behaviors among individuals with substance use disorders (SUDs).

This Advisory is based on TIP 31, Screening and Assessing Adolescents for Substance Use Disorders (SUDs) and TIP 32, Treatment of Adolescents with SUDs. It includes recommendations for engaging adolescents in SUD risk assessment, screening, and treatment.